{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:51:25Z","timestamp":1787241085458,"version":"build-2736575974"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"16","license":[{"start":{"date-parts":[[2013,4,22]],"date-time":"2013-04-22T00:00:00Z","timestamp":1366588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,4,22]],"date-time":"2013-04-22T00:00:00Z","timestamp":1366588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2014,4,17]]},"DOI":"10.1038\/onc.2013.147","type":"journal-article","created":{"date-parts":[[2013,4,22]],"date-time":"2013-04-22T08:18:04Z","timestamp":1366618684000},"page":"2134-2144","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Protein kinase C\u03b1 suppresses Kras-mediated lung tumor formation through activation of a p38 MAPK-TGF\u03b2 signaling axis"],"prefix":"10.1038","volume":"33","author":[{"given":"K S","family":"Hill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Erdogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Khoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M P","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Leitges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N R","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A P","family":"Fields","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,4,22]]},"reference":[{"key":"BFonc2013147_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.20138","volume":"62","author":"R Siegel","year":"2012","unstructured":"Siegel R, Naishadham D, Jemal A . Cancer statistics, 2012. CA Cancer J Clin 2012; 62: 10\u201329.","journal-title":"CA Cancer J Clin"},{"key":"BFonc2013147_CR2","doi-asserted-by":"crossref","first-page":"7847","DOI":"10.1016\/S0021-9258(18)34459-4","volume":"257","author":"M Castagna","year":"1982","unstructured":"Castagna M, Takai Y, Kaibuchi K, Sano K, Kikkawa U, Nishizuka Y . Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J Biol Chem 1982; 257: 7847\u20137851.","journal-title":"J Biol Chem"},{"key":"BFonc2013147_CR3","doi-asserted-by":"crossref","first-page":"11442","DOI":"10.1016\/S0021-9258(17)44245-1","volume":"258","author":"U Kikkawa","year":"1983","unstructured":"Kikkawa U, Takai Y, Tanaka Y, Miyake R, Nishizuka Y . Protein kinase C as a possible receptor protein of tumor-promoting phorbol esters. J Biol Chem 1983; 258: 11442\u201311445.","journal-title":"J Biol Chem"},{"key":"BFonc2013147_CR4","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.advenzreg.2007.11.014","volume":"48","author":"AP Fields","year":"2008","unstructured":"Fields AP, Murray NR . Protein kinase C isozymes as therapeutic targets for treatment of human cancers. Adv Enzyme Regul 2008; 48: 166\u2013178.","journal-title":"Adv Enzyme Regul"},{"key":"BFonc2013147_CR5","first-page":"2517","volume":"13","author":"AM Cacace","year":"1996","unstructured":"Cacace AM, Ueffing M, Philipp A, Han EK, Kolch W, Weinstein IB . PKC epsilon functions as an oncogene by enhancing activation of the Raf kinase. Oncogene 1996; 13: 2517\u20132526.","journal-title":"Oncogene"},{"key":"BFonc2013147_CR6","doi-asserted-by":"crossref","first-page":"6090","DOI":"10.1016\/S0021-9258(18)53223-3","volume":"268","author":"H Mischak","year":"1993","unstructured":"Mischak H, Goodnight JA, Kolch W, Martiny-Baron G, Schaechtle C, Kazanietz MG et al. Overexpression of protein kinase C-delta and -epsilon in NIH 3T3 cells induces opposite effects on growth, morphology, anchorage dependence, and tumorigenicity. J Biol Chem 1993; 268: 6090\u20136096.","journal-title":"J Biol Chem"},{"key":"BFonc2013147_CR7","first-page":"5710","volume":"59","author":"PJ Reddig","year":"1999","unstructured":"Reddig PJ, Dreckschmidt NE, Ahrens H, Simsiman R, Tseng CP, Zou J et al. Transgenic mice overexpressing protein kinase Cdelta in the epidermis are resistant to skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res 1999; 59: 5710\u20135718.","journal-title":"Cancer Res"},{"key":"BFonc2013147_CR8","first-page":"595","volume":"60","author":"PJ Reddig","year":"2000","unstructured":"Reddig PJ, Dreckschmidt NE, Zou J, Bourguignon SE, Oberley TD, Verma AK . Transgenic mice overexpressing protein kinase C epsilon in their epidermis exhibit reduced papilloma burden but enhanced carcinoma formation after tumor promotion. Cancer Res 2000; 60: 595\u2013602.","journal-title":"Cancer Res"},{"issue":"Pt 5","key":"BFonc2013147_CR9","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1042\/BST0350996","volume":"35","author":"AP Fields","year":"2007","unstructured":"Fields AP, Frederick LA, Regala RP . Targeting the oncogenic protein kinase Ciota signalling pathway for the treatment of cancer. Biochem Soc Trans 2007; 35 (Pt 5): 996\u20131000.","journal-title":"Biochem Soc Trans"},{"key":"BFonc2013147_CR10","volume-title":"Protein Kinase C in Cancer Signaling and Therapy","author":"V Justilien","year":"2010","unstructured":"Justilien V, Fields A . Atypical PKCs as targets for cancer therapy. In: Kazanietz M, eds. Protein Kinase C in Cancer Signaling and Therapy. Springer, London, 2010."},{"key":"BFonc2013147_CR11","doi-asserted-by":"publisher","first-page":"8905","DOI":"10.1158\/0008-5472.CAN-05-2372","volume":"65","author":"RP Regala","year":"2005","unstructured":"Regala RP, Weems C, Jamieson L, Khoor A, Edell ES, Lohse CM et al. Atypical protein kinase C iota is an oncogene in human non-small cell lung cancer. Cancer Res 2005; 65: 8905\u20138911.","journal-title":"Cancer Res"},{"key":"BFonc2013147_CR12","doi-asserted-by":"publisher","first-page":"31109","DOI":"10.1074\/jbc.M505402200","volume":"280","author":"RP Regala","year":"2005","unstructured":"Regala RP, Weems C, Jamieson L, Copland JA, Thompson EA, Fields AP . Atypical protein kinase Ciota plays a critical role in human lung cancer cell growth and tumorigenicity. J Biol Chem 2005; 280: 31109\u201331115.","journal-title":"J Biol Chem"},{"key":"BFonc2013147_CR13","doi-asserted-by":"publisher","first-page":"7603","DOI":"10.1158\/0008-5472.CAN-09-2066","volume":"69","author":"RP Regala","year":"2009","unstructured":"Regala RP, Davis RK, Kunz A, Khoor A, Leitges M, Fields AP . Atypical protein kinase C\u03b9 is required for bronchioalveolar stem cell expansion and lung tumorigenesis. Cancer Res 2009; 69: 7603\u20137611.","journal-title":"Cancer Res"},{"key":"BFonc2013147_CR14","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1083\/jcb.200311011","volume":"164","author":"NR Murray","year":"2004","unstructured":"Murray NR, Jamieson L, Yu W, Zhang J, Gokmen-Polar Y, Sier D et al. Protein kinase Ciota is required for Ras transformation and colon carcinogenesis in vivo. J Cell Biol 2004; 164: 797\u2013802.","journal-title":"J Cell Biol"},{"key":"BFonc2013147_CR15","doi-asserted-by":"publisher","first-page":"12519","DOI":"10.1073\/pnas.0505641102","volume":"102","author":"AM Eder","year":"2005","unstructured":"Eder AM, Sui X, Rosen DG, Nolden LK, Cheng KW, Lahad JP et al. Atypical PKCiota contributes to poor prognosis through loss of apical-basal polarity and cyclin E overexpression in ovarian cancer. Proc Natl Acad Sci USA 2005; 102: 12519\u201312524.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2013147_CR16","doi-asserted-by":"publisher","first-page":"4627","DOI":"10.1158\/0008-5472.CAN-05-4527","volume":"66","author":"L Zhang","year":"2006","unstructured":"Zhang L, Huang J, Yang N, Liang S, Barchetti A, Giannakakis A et al. Integrative genomic analysis of protein kinase C (PKC) family identifies PKCiota as a biomarker and potential oncogene in ovarian carcinoma. Cancer Res 2006; 66: 4627\u20134635.","journal-title":"Cancer Res"},{"key":"BFonc2013147_CR17","doi-asserted-by":"publisher","first-page":"3927","DOI":"10.1074\/jbc.274.7.3927","volume":"274","author":"L Jamieson","year":"1999","unstructured":"Jamieson L, Carpenter L, Biden TJ, Fields AP . Protein kinase Ciota activity is necessary for Bcr-Abl-mediated resistance to drug-induced apoptosis. J Biol Chem 1999; 274: 3927\u20133930.","journal-title":"J Biol Chem"},{"key":"BFonc2013147_CR18","doi-asserted-by":"publisher","first-page":"27521","DOI":"10.1074\/jbc.272.44.27521","volume":"272","author":"NR Murray","year":"1997","unstructured":"Murray NR, Fields AP . Atypical protein kinase Ciota protects human leukemia cells against drug-induced apoptosis. J Biol Chem 1997; 272: 27521\u201327524.","journal-title":"J Biol Chem"},{"key":"BFonc2013147_CR19","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1158\/0008-5472.CAN-09-2684","volume":"70","author":"ML Scotti","year":"2010","unstructured":"Scotti ML, Bamlet WR, Smyrk TC, Fields AP, Murray NR . Protein kinase C\u03b9 is required for pancreatic cancer cell transformed growth and tumorigenesis. Cancer Res 2010; 70: 2064\u20132074.","journal-title":"Cancer Res"},{"key":"BFonc2013147_CR20","doi-asserted-by":"publisher","first-page":"e30509","DOI":"10.1371\/journal.pone.0030509","volume":"7","author":"ML Scotti","year":"2012","unstructured":"Scotti ML, Smith KE, Butler AM, Calcagno SR, Crawford HC, Leitges M et al. Protein kinase Ciota regulates pancreatic acinar-to-ductal metaplasia. PLoS One 2012; 7: e30509.","journal-title":"PLoS One"},{"key":"BFonc2013147_CR21","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/onc.2012.46","volume":"32","author":"K Kikuchi","year":"2013","unstructured":"Kikuchi K, Soundararajan A, Zarzabal LA, Weems CR, Nelon LD, Hampton ST et al. Protein kinase Ciota as a therapeutic target in alveolar rhabdomyosarcoma. Oncogene 2013; 32: 286\u2013295.","journal-title":"Oncogene"},{"key":"BFonc2013147_CR22","doi-asserted-by":"publisher","first-page":"28450","DOI":"10.1074\/jbc.M606054200","volume":"281","author":"E Erdogan","year":"2006","unstructured":"Erdogan E, Lamark T, Stallings-Mann M, Lee J, Pellecchia M, Thompson EA et al. Aurothiomalate inhibits transformed growth by targeting the PB1 domain of protein kinase Ciota. J Biol Chem 2006; 281: 28450\u201328459.","journal-title":"J Biol Chem"},{"key":"BFonc2013147_CR23","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1158\/0008-5472.CAN-05-3405","volume":"66","author":"M Stallings-Mann","year":"2006","unstructured":"Stallings-Mann M, Jamieson L, Regala RP, Weems C, Murray NR, Fields AP . A novel small-molecule inhibitor of protein kinase Ciota blocks transformed growth of non-small-cell lung cancer cells. Cancer Res 2006; 66: 1767\u20131774.","journal-title":"Cancer Res"},{"key":"BFonc2013147_CR24","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1158\/1541-7786.MCR-09-0358","volume":"8","author":"I Nazarenko","year":"2010","unstructured":"Nazarenko I, Jenny M, Keil J, Gieseler C, Weisshaupt K, Sehouli J et al. Atypical protein kinase C zeta exhibits a proapoptotic function in ovarian cancer. Mol Cancer Res 2010; 8: 919\u2013934.","journal-title":"Mol Cancer Res"},{"key":"BFonc2013147_CR25","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1128\/MCB.01294-08","volume":"29","author":"AS Galvez","year":"2009","unstructured":"Galvez AS, Duran A, Linares JF, Pathrose P, Castilla EA, Abu-Baker S et al. Protein kinase Czeta represses the interleukin-6 promoter and impairs tumorigenesis in vivo. Mol Cell Biol 2009; 29: 104\u2013115.","journal-title":"Mol Cell Biol"},{"key":"BFonc2013147_CR26","doi-asserted-by":"publisher","first-page":"4320","DOI":"10.1158\/0008-5472.CAN-06-2486","volume":"67","author":"YH Hsieh","year":"2007","unstructured":"Hsieh YH, Wu TT, Huang CY, Hsieh YS, Hwang JM, Liu JY . p38 mitogen-activated protein kinase pathway is involved in protein kinase Calpha-regulated invasion in human hepatocellular carcinoma cells. Cancer Res 2007; 67: 4320\u20134327.","journal-title":"Cancer Res"},{"key":"BFonc2013147_CR27","doi-asserted-by":"publisher","first-page":"33753","DOI":"10.1074\/jbc.M303313200","volume":"278","author":"Y Tanaka","year":"2003","unstructured":"Tanaka Y, Gavrielides MV, Mitsuuchi Y, Fujii T, Kazanietz MG . Protein kinase C promotes apoptosis in LNCaP prostate cancer cells through activation of p38 MAPK and inhibition of the Akt survival pathway. J Biol Chem 2003; 278: 33753\u201333762.","journal-title":"J Biol Chem"},{"key":"BFonc2013147_CR28","doi-asserted-by":"publisher","first-page":"6955","DOI":"10.1158\/0008-5472.CAN-06-0268","volume":"66","author":"H Oster","year":"2006","unstructured":"Oster H, Leitges M . Protein kinase C alpha but not PKCzeta suppresses intestinal tumor formation in ApcMin\/+ mice. Cancer Res 2006; 66: 6955\u20136963.","journal-title":"Cancer Res"},{"key":"BFonc2013147_CR29","doi-asserted-by":"publisher","first-page":"5466","DOI":"10.1074\/jbc.M707576200","volume":"283","author":"JL Oliva","year":"2008","unstructured":"Oliva JL, Caino MC, Senderowicz AM, Kazanietz MG . S-phase-specific activation of PKC\u03b1 induces senescence in non-small cell lung cancer cells. J Biol Chem 2008; 283: 5466\u20135476.","journal-title":"J Biol Chem"},{"key":"BFonc2013147_CR30","doi-asserted-by":"publisher","first-page":"33926","DOI":"10.1074\/jbc.M505748200","volume":"280","author":"M Nakagawa","year":"2005","unstructured":"Nakagawa M, Oliva JL, Kothapalli D, Fournier A, Assoian RK, Kazanietz MG . Phorbol ester-induced G1 phase arrest selectively mediated by protein kinase Cdelta-dependent induction of p21. J Biol Chem 2005; 280: 33926\u201333934.","journal-title":"J Biol Chem"},{"key":"BFonc2013147_CR31","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1101\/gad.943001","volume":"15","author":"EL Jackson","year":"2001","unstructured":"Jackson EL, Willis N, Mercer K, Bronson RT, Crowley D, Montoya R et al. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev 2001; 15: 3243\u20133248.","journal-title":"Genes Dev"},{"key":"BFonc2013147_CR32","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1038\/35074129","volume":"410","author":"L Johnson","year":"2001","unstructured":"Johnson L, Mercer K, Greenbaum D, Bronson RT, Crowley D, Tuveson DA et al. Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature 2001; 410: 1111\u20131116.","journal-title":"Nature"},{"key":"BFonc2013147_CR33","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1158\/0008-5472.CAN-03-3376","volume":"64","author":"AY Nikitin","year":"2004","unstructured":"Nikitin AY, Alcaraz A, Anver MR, Bronson RT, Cardiff RD, Dixon D et al. Classification of proliferative pulmonary lesions of the mouse: recommendations of the mouse models of human cancers consortium. Cancer Res 2004; 64: 2307\u20132316.","journal-title":"Cancer Res"},{"key":"BFonc2013147_CR34","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nrc2772","volume":"10","author":"M Collado","year":"2010","unstructured":"Collado M, Serrano M . Senescence in tumours: evidence from mice and humans. Nat Rev Cancer 2010; 10: 51\u201357.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2013147_CR35","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/S0092-8674(00)81902-9","volume":"88","author":"M Serrano","year":"1997","unstructured":"Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW . Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 1997; 88: 593\u2013602.","journal-title":"Cell"},{"key":"BFonc2013147_CR36","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.cell.2005.03.032","volume":"121","author":"CF Kim","year":"2005","unstructured":"Kim CF, Jackson EL, Woolfenden AE, Lawrence S, Babar I, Vogel S et al. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 2005; 121: 823\u2013835.","journal-title":"Cell"},{"key":"BFonc2013147_CR37","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1046\/j.1365-2443.2003.00620.x","volume":"8","author":"H Iwasa","year":"2003","unstructured":"Iwasa H, Han J, Ishikawa F . Mitogen-activated protein kinase p38 defines the common senescence-signalling pathway. Genes Cells 2003; 8: 131\u2013144.","journal-title":"Genes Cells"},{"key":"BFonc2013147_CR38","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1128\/MCB.22.10.3389-3403.2002","volume":"22","author":"W Wang","year":"2002","unstructured":"Wang W, Chen JX, Liao R, Deng Q, Zhou JJ, Huang S et al. Sequential activation of the MEK-extracellular signal-regulated kinase and MKK3\/6-p38 mitogen-activated protein kinase pathways mediates oncogenic ras-induced premature senescence. Mol Cell Biol 2002; 22: 3389\u20133403.","journal-title":"Mol Cell Biol"},{"key":"BFonc2013147_CR39","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/ng2037","volume":"39","author":"JJ Ventura","year":"2007","unstructured":"Ventura JJ, Tenbaum S, Perdiguero E, Huth M, Guerra C, Barbacid M et al. p38alpha MAP kinase is essential in lung stem and progenitor cell proliferation and differentiation. Nat Genet 2007; 39: 750\u2013758.","journal-title":"Nat Genet"},{"key":"BFonc2013147_CR40","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/nrm1175","volume":"4","author":"S Grunert","year":"2003","unstructured":"Grunert S, Jechlinger M, Beug H . Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. Nat Rev Mol Cell Biol 2003; 4: 657\u2013665.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFonc2013147_CR41","doi-asserted-by":"publisher","first-page":"18104","DOI":"10.1074\/jbc.M110.208488","volume":"286","author":"F Hao","year":"2011","unstructured":"Hao F, Pysz MA, Curry KJ, Haas KN, Seedhouse SJ, Black AR et al. Protein kinase Calpha signaling regulates inhibitor of DNA binding 1 in the intestinal epithelium. J Biol Chem 2011; 286: 18104\u201318117.","journal-title":"J Biol Chem"},{"key":"BFonc2013147_CR42","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/j.yexcr.2009.02.002","volume":"315","author":"MA Pysz","year":"2009","unstructured":"Pysz MA, Leontieva OV, Bateman NW, Uronis JM, Curry KJ, Threadgill DW et al. PKC\u03b1 tumor suppression in the intestine is associated with transcriptional and translational inhibition of cyclin D1. Exp Cell Res 2009; 315: 1415\u20131428.","journal-title":"Exp Cell Res"},{"key":"BFonc2013147_CR43","doi-asserted-by":"publisher","first-page":"3940","DOI":"10.1172\/JCI44165","volume":"120","author":"S Vicent","year":"2010","unstructured":"Vicent S, Chen R, Sayles LC, Lin C, Walker RG, Gillespie AK et al. Wilms tumor 1 (WT1) regulates KRAS-driven oncogenesis and senescence in mouse and human models. J Clin Invest 2010; 120: 3940\u20133952.","journal-title":"J Clin Invest"},{"key":"BFonc2013147_CR44","first-page":"519","volume":"233","author":"AP Fields","year":"2003","unstructured":"Fields AP, Gustafson WC . Protein kinase C in disease: cancer. Methods Mol Biol 2003; 233: 519\u2013537.","journal-title":"Methods Mol Biol"},{"key":"BFonc2013147_CR45","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.molcel.2006.01.012","volume":"21","author":"TG Bivona","year":"2006","unstructured":"Bivona TG, Quatela SE, Bodemann BO, Ahearn IM, Soskis MJ, Mor A et al. PKC regulates a farnesyl-electrostatic switch on K-Ras that promotes its association with Bcl-XL on mitochondria and induces apoptosis. Mol Cell 2006; 21: 481\u2013493.","journal-title":"Mol Cell"},{"key":"BFonc2013147_CR46","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1159\/000257518","volume":"24","author":"I Tossidou","year":"2009","unstructured":"Tossidou I, Starker G, Kruger J, Meier M, Leitges M, Haller H et al. PKC-alpha modulates TGF-beta signaling and impairs podocyte survival. Cell Physiol Biochem 2009; 24: 627\u2013634.","journal-title":"Cell Physiol Biochem"},{"key":"BFonc2013147_CR47","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1161\/01.HYP.0000087839.72582.DD","volume":"42","author":"C Lindschau","year":"2003","unstructured":"Lindschau C, Quass P, Menne J, Guler F, Fiebeler A, Leitges M et al. Glucose-induced TGF-beta1 and TGF-beta receptor-1 expression in vascular smooth muscle cells is mediated by protein kinase C-alpha. Hypertension 2003; 42: 335\u2013341.","journal-title":"Hypertension"},{"key":"BFonc2013147_CR48","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1210\/en.2004-1377","volume":"146","author":"X Luo","year":"2005","unstructured":"Luo X, Ding L, Xu J, Chegini N . Gene expression profiling of leiomyoma and myometrial smooth muscle cells in response to transforming growth factor-beta. Endocrinology 2005; 146: 1097\u20131118.","journal-title":"Endocrinology"},{"key":"BFonc2013147_CR49","first-page":"3499","volume":"56","author":"N Dean","year":"1996","unstructured":"Dean N, McKay R, Miraglia L, Howard R, Cooper S, Giddings J et al. Inhibition of growth of human tumor cell lines in nude mice by an antisense of oligonucleotide inhibitor of protein kinase C-alpha expression. Cancer Res 1996; 56: 3499\u20133507.","journal-title":"Cancer Res"},{"key":"BFonc2013147_CR50","first-page":"35","volume":"13","author":"T Geiger","year":"1998","unstructured":"Geiger T, Muller M, Dean NM, Fabbro D . Antitumor activity of a PKC-alpha antisense oligonucleotide in combination with standard chemotherapeutic agents against various human tumors transplanted into nude mice. Anticancer Drug Des 1998; 13: 35\u201345.","journal-title":"Anticancer Drug Des"},{"key":"BFonc2013147_CR51","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/cncr.11909","volume":"100","author":"R Advani","year":"2004","unstructured":"Advani R, Peethambaram P, Lum BL, Fisher GA, Hartmann L, Long HJ et al. A phase II trial of aprinocarsen, an antisense oligonucleotide inhibitor of protein kinase C alpha, administered as a 21-day infusion to patients with advanced ovarian carcinoma. Cancer 2004; 100: 321\u2013326.","journal-title":"Cancer"},{"key":"BFonc2013147_CR52","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1215\/S1152851703000353","volume":"7","author":"SA Grossman","year":"2005","unstructured":"Grossman SA, Alavi JB, Supko JG, Carson KA, Priet R, Dorr FA et al. Efficacy and toxicity of the antisense oligonucleotide aprinocarsen directed against protein kinase C-alpha delivered as a 21-day continuous intravenous infusion in patients with recurrent high-grade astrocytomas. Neuro Oncol 2005; 7: 32\u201340.","journal-title":"Neuro Oncol"},{"key":"BFonc2013147_CR53","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1200\/JCO.2005.04.3299","volume":"24","author":"L Paz-Ares","year":"2006","unstructured":"Paz-Ares L, Douillard JY, Koralewski P, Manegold C, Smit EF, Reyes JM et al. Phase III study of gemcitabine and cisplatin with or without aprinocarsen, a protein kinase C-alpha antisense oligonucleotide, in patients with advanced-stage non-small-cell lung cancer. J Clin Oncol 2006; 24: 1428\u20131434.","journal-title":"J Clin Oncol"},{"key":"BFonc2013147_CR54","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-79054-1","volume-title":"Introductory Statistics with R","author":"P Dalgaard","year":"2008","unstructured":"Dalgaard P . Introductory Statistics with R. 2nd edition, (ed) Springer, New York, 2008."},{"key":"BFonc2013147_CR55","doi-asserted-by":"crossref","unstructured":"Smyth GK . Limma: linear models for microarray data. Bioinformatics and Computational Biology Solutions using R and Bioconductor In: Gentleman R., Carey V., Dudoit S., Irizarry R., Huber W, (eds). Springer, New York, pp 397\u2013420.","DOI":"10.1007\/0-387-29362-0_23"},{"key":"BFonc2013147_CR56","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/ijc.25704","volume":"129","author":"A Sanchez-Palencia","year":"2011","unstructured":"Sanchez-Palencia A, Gomez-Morales M, Gomez-Capilla JA, Pedraza V, Boyero L, Rosell R et al. Gene expression profiling reveals novel biomarkers in nonsmall cell lung cancer. Int J Cancer 2011; 129: 355\u2013364.","journal-title":"Int J Cancer"},{"key":"BFonc2013147_CR57","doi-asserted-by":"publisher","first-page":"e10312","DOI":"10.1371\/journal.pone.0010312","volume":"5","author":"J Hou","year":"2010","unstructured":"Hou J, Aerts J, den Hamer B, van Ijcken W, den Bakker M, Riegman P et al. Gene expression-based classification of non-small cell lung carcinomas and survival prediction. PLoS One 2010; 5: e10312.","journal-title":"PLoS One"},{"key":"BFonc2013147_CR58","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.lungcan.2006.12.010","volume":"56","author":"E Dehan","year":"2007","unstructured":"Dehan E, Ben-Dor A, Liao W, Lipson D, Frimer H, Rienstein S et al. Chromosomal aberrations and gene expression profiles in non-small cell lung cancer. Lung Cancer 2007; 56: 175\u2013184.","journal-title":"Lung Cancer"},{"key":"BFonc2013147_CR59","first-page":"847","volume":"16","author":"M Leitges","year":"2002","unstructured":"Leitges M, Plomann M, Standaert ML, Bandyopadhyay G, Sajan MP, Kanoh Y et al. Knockout of PKC alpha enhances insulin signaling through PI3K. Mol Endocrinol 2002; 16: 847\u2013858.","journal-title":"Mol Endocrinol"},{"key":"BFonc2013147_CR60","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1172\/JCI2732","volume":"102","author":"A Fasbender","year":"1998","unstructured":"Fasbender A, Lee JH, Walters RW, Moninger TO, Zabner J, Welsh MJ . Incorporation of adenovirus in calcium phosphate precipitates enhances gene transfer to airway epithelia in vitro and in vivo. J Clin Invest 1998; 102: 184\u2013193.","journal-title":"J Clin Invest"},{"key":"BFonc2013147_CR61","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S1535-6108(04)00085-6","volume":"5","author":"DA Tuveson","year":"2004","unstructured":"Tuveson DA, Shaw AT, Willis NA, Silver DP, Jackson EL, Chang S et al. Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects. Cancer Cell 2004; 5: 375\u2013387.","journal-title":"Cancer Cell"},{"key":"BFonc2013147_CR62","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1093\/jnci\/75.5.971","volume":"75","author":"AM Malkinson","year":"1985","unstructured":"Malkinson AM, Nesbitt MN, Skamene E . Susceptibility to urethan-induced pulmonary adenomas between A\/J and C57BL\/6J mice: use of AXB and BXA recombinant inbred lines indicating a three-locus genetic model. J Natl Cancer Inst 1985; 75: 971\u2013974.","journal-title":"J Natl Cancer Inst"},{"key":"BFonc2013147_CR63","doi-asserted-by":"publisher","first-page":"e26439","DOI":"10.1371\/journal.pone.0026439","volume":"6","author":"R Regala","year":"2011","unstructured":"Regala R, Justilien V, Walsh MP, Weems C, Khoor A, Murray NR et al. Matrix metalloproteinase-10 promotes kras-mediated bronchio-alveolar stem cell expansion and lung cancer formation. PLoS One 2011; 6: e26439.","journal-title":"PLoS One"},{"key":"BFonc2013147_CR64","doi-asserted-by":"publisher","first-page":"e2220","DOI":"10.1371\/journal.pone.0002220","volume":"3","author":"Y Yang","year":"2008","unstructured":"Yang Y, Iwanaga K, Raso MG, Wislez M, Hanna AE, Wieder ED et al. Phosphatidylinositol 3-kinase mediates bronchioalveolar stem cell expansion in mouse models of oncogenic K-ras-induced lung cancer. PLoS One 2008; 3: e2220.","journal-title":"PLoS One"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2013147.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2013147","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2013147.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T15:29:07Z","timestamp":1647876547000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2013147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,22]]},"references-count":64,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2014,4,17]]}},"alternative-id":["BFonc2013147"],"URL":"https:\/\/doi.org\/10.1038\/onc.2013.147","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,22]]},"assertion":[{"value":"13 December 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2013","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2013","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2013","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}